1. Home
  2. RHI vs TLX Comparison

RHI vs TLX Comparison

Compare RHI & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

SELL

Current Price

$34.15

Market Cap

3.9B

ML Signal

SELL

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$10.89

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RHI
TLX
Founded
1948
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
RHI
TLX
Price
$34.15
$10.89
Analyst Decision
Hold
Strong Buy
Analyst Count
11
5
Target Price
★ $35.00
$19.60
AVG Volume (30 Days)
★ 1.5M
484.9K
Earning Date
10-21-2026
10-15-2026
Dividend Yield
★ 6.53%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.40
N/A
Revenue
★ $5,378,506,000.00
N/A
Revenue This Year
N/A
$15.66
Revenue Next Year
$4.14
$17.60
P/E Ratio
★ $94.48
$150.33
Revenue Growth
N/A
★ N/A
52 Week Low
$21.83
$6.28
52 Week High
$46.70
$13.11

Technical Indicators

Market Signals
Indicator
RHI
TLX
Relative Strength Index (RSI) 32.11 44.22
Support Level $26.24 $10.01
Resistance Level $35.58 $11.48
Average True Range (ATR) 1.34 0.35
MACD -0.13 -0.14
Stochastic Oscillator 11.55 7.32

Price Performance

Historical Comparison
RHI
TLX

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: